AVEO Pharmaceuticals News
Most Popular AVEO Pharmaceuticals Story
Tivozanib - 10 promising late-stage cancer drugs
Tuan Ha-Ngoc, the president and CEO of Aveo Pharmaceuticals ($AVEO), is leading a very smart charge to advance tivozanib to the market for kidney cancers called advanced renal cell carcinoma (RCC). Read more...
Latest Headlines
- July 12, 2011
- June 15, 2011
- May 31, 2011
- April 12, 2011
- April 4, 2011
- February 17, 2011
- January 20, 2011
- October 1, 2010
- April 14, 2010
- March 11, 2010
- January 20, 2010
- December 17, 2009
- July 21, 2009
- January 28, 2008
- October 2, 2007
- August 15, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
